HMOX-1 inhibits TGF-β-induced epithelial-mesenchymal transition in the MCF-7 breast cancer cell line.

about

HMOX-1 inhibits TGF-β-induced epithelial-mesenchymal transition in the MCF-7 breast cancer cell line.

Item

http://www.wikidata.org/entity/Q38699902

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

HMOX-1 inhibits TGF-β-induced ...... MCF-7 breast cancer cell line.

@en

type

Item

label

HMOX-1 inhibits TGF-β-induced ...... MCF-7 breast cancer cell line.

@en

prefLabel

HMOX-1 inhibits TGF-β-induced ...... MCF-7 breast cancer cell line.

@en

P1476

HMOX-1 inhibits TGF-β-induced ...... MCF-7 breast cancer cell line.

@en

P2093

Fanli Kong

http://www.w3.org/2001/XMLSchema#string

Feng Zeng

http://www.w3.org/2001/XMLSchema#string

Jieyi Ma

http://www.w3.org/2001/XMLSchema#string

Lili Zeng

http://www.w3.org/2001/XMLSchema#string

Shuichuan Huang

http://www.w3.org/2001/XMLSchema#string

Suhong Sun

http://www.w3.org/2001/XMLSchema#string

Xiaofeng Zhu

http://www.w3.org/2001/XMLSchema#string

Xiaoming Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

Transforming Growth Factor-Beta and Oxidative Stress Interplay: Implications in Tumorigenesis and Cancer Progression

Regulation of signal transduction by reactive oxygen species in the cardiovascular system

Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives.

New paradigms for the treatment of cancer: the role of anti-angiogenesis agents.

Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition.

The role of TGFBI in mesothelioma and breast cancer: association with tumor suppression.

Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices.

Heme oxygenase-1 in tumors: is it a false friend?

Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells.

Targeting the TGFβ signalling pathway in disease.

P304

411-417

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/IJMM.2017.3027

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28627599

http://www.w3.org/2001/XMLSchema#string

P932

5505025

http://www.w3.org/2001/XMLSchema#string